2023-03-142024-08-312024-08-31false14728386BRIDGEOUT HEALTHCARE SERVICES LTD2024-11-3078109iso4217:GBPxbrli:pure147283862023-03-14147283862024-08-31147283862023-03-142024-08-31147283862023-03-13147283862023-03-13147283862023-03-132023-03-1314728386bus:SmallEntities2023-03-142024-08-3114728386bus:AuditExempt-NoAccountantsReport2023-03-142024-08-3114728386bus:FullAccounts2023-03-142024-08-3114728386bus:PrivateLimitedCompanyLtd2023-03-142024-08-3114728386core:WithinOneYear2024-08-3114728386core:AfterOneYear2024-08-3114728386core:WithinOneYear2023-03-1314728386core:AfterOneYear2023-03-1314728386core:ShareCapital2024-08-3114728386core:SharePremium2024-08-3114728386core:RevaluationReserve2024-08-3114728386core:OtherReservesSubtotal2024-08-3114728386core:RetainedEarningsAccumulatedLosses2024-08-3114728386core:ShareCapital2023-03-1314728386core:SharePremium2023-03-1314728386core:RevaluationReserve2023-03-1314728386core:OtherReservesSubtotal2023-03-1314728386core:RetainedEarningsAccumulatedLosses2023-03-1314728386core:LandBuildings2024-08-3114728386core:PlantMachinery2024-08-3114728386core:Vehicles2024-08-3114728386core:FurnitureFittings2024-08-3114728386core:OfficeEquipment2024-08-3114728386core:NetGoodwill2024-08-3114728386core:IntangibleAssetsOtherThanGoodwill2024-08-3114728386core:ListedExchangeTraded2024-08-3114728386core:UnlistedNon-exchangeTraded2024-08-3114728386core:LandBuildings2023-03-1314728386core:PlantMachinery2023-03-1314728386core:Vehicles2023-03-1314728386core:FurnitureFittings2023-03-1314728386core:OfficeEquipment2023-03-1314728386core:NetGoodwill2023-03-1314728386core:IntangibleAssetsOtherThanGoodwill2023-03-1314728386core:ListedExchangeTraded2023-03-1314728386core:UnlistedNon-exchangeTraded2023-03-1314728386core:LandBuildings2023-03-142024-08-3114728386core:PlantMachinery2023-03-142024-08-3114728386core:Vehicles2023-03-142024-08-3114728386core:FurnitureFittings2023-03-142024-08-3114728386core:OfficeEquipment2023-03-142024-08-3114728386core:NetGoodwill2023-03-142024-08-3114728386core:IntangibleAssetsOtherThanGoodwill2023-03-142024-08-3114728386core:ListedExchangeTraded2023-03-142024-08-3114728386core:UnlistedNon-exchangeTraded2023-03-142024-08-3114728386core:MoreThanFiveYears2023-03-142024-08-3114728386core:Non-currentFinancialInstruments2024-08-3114728386core:Non-currentFinancialInstruments2023-03-1314728386dpl:CostSales2023-03-142024-08-3114728386dpl:DistributionCosts2023-03-142024-08-3114728386core:LandBuildings2023-03-142024-08-3114728386core:PlantMachinery2023-03-142024-08-3114728386core:Vehicles2023-03-142024-08-3114728386core:FurnitureFittings2023-03-142024-08-3114728386core:OfficeEquipment2023-03-142024-08-3114728386dpl:AdministrativeExpenses2023-03-142024-08-3114728386core:NetGoodwill2023-03-142024-08-3114728386core:IntangibleAssetsOtherThanGoodwill2023-03-142024-08-3114728386dpl:GroupUndertakings2023-03-142024-08-3114728386dpl:ParticipatingInterests2023-03-142024-08-3114728386dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-142024-08-3114728386core:ListedExchangeTraded2023-03-142024-08-3114728386dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-142024-08-3114728386core:UnlistedNon-exchangeTraded2023-03-142024-08-3114728386dpl:CostSales2023-03-132023-03-1314728386dpl:DistributionCosts2023-03-132023-03-1314728386core:LandBuildings2023-03-132023-03-1314728386core:PlantMachinery2023-03-132023-03-1314728386core:Vehicles2023-03-132023-03-1314728386core:FurnitureFittings2023-03-132023-03-1314728386core:OfficeEquipment2023-03-132023-03-1314728386dpl:AdministrativeExpenses2023-03-132023-03-1314728386core:NetGoodwill2023-03-132023-03-1314728386core:IntangibleAssetsOtherThanGoodwill2023-03-132023-03-1314728386dpl:GroupUndertakings2023-03-132023-03-1314728386dpl:ParticipatingInterests2023-03-132023-03-1314728386dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-132023-03-1314728386core:ListedExchangeTraded2023-03-132023-03-1314728386dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-132023-03-1314728386core:UnlistedNon-exchangeTraded2023-03-132023-03-1314728386core:NetGoodwill2024-08-3114728386core:IntangibleAssetsOtherThanGoodwill2024-08-3114728386core:LandBuildings2024-08-3114728386core:PlantMachinery2024-08-3114728386core:Vehicles2024-08-3114728386core:FurnitureFittings2024-08-3114728386core:OfficeEquipment2024-08-3114728386core:AfterOneYear2024-08-3114728386core:WithinOneYear2024-08-3114728386core:ListedExchangeTraded2024-08-3114728386core:UnlistedNon-exchangeTraded2024-08-3114728386core:ShareCapital2024-08-3114728386core:SharePremium2024-08-3114728386core:RevaluationReserve2024-08-3114728386core:OtherReservesSubtotal2024-08-3114728386core:RetainedEarningsAccumulatedLosses2024-08-3114728386core:NetGoodwill2023-03-1314728386core:IntangibleAssetsOtherThanGoodwill2023-03-1314728386core:LandBuildings2023-03-1314728386core:PlantMachinery2023-03-1314728386core:Vehicles2023-03-1314728386core:FurnitureFittings2023-03-1314728386core:OfficeEquipment2023-03-1314728386core:AfterOneYear2023-03-1314728386core:WithinOneYear2023-03-1314728386core:ListedExchangeTraded2023-03-1314728386core:UnlistedNon-exchangeTraded2023-03-1314728386core:ShareCapital2023-03-1314728386core:SharePremium2023-03-1314728386core:RevaluationReserve2023-03-1314728386core:OtherReservesSubtotal2023-03-1314728386core:RetainedEarningsAccumulatedLosses2023-03-1314728386core:NetGoodwill2023-03-1314728386core:IntangibleAssetsOtherThanGoodwill2023-03-1314728386core:LandBuildings2023-03-1314728386core:PlantMachinery2023-03-1314728386core:Vehicles2023-03-1314728386core:FurnitureFittings2023-03-1314728386core:OfficeEquipment2023-03-1314728386core:AfterOneYear2023-03-1314728386core:WithinOneYear2023-03-1314728386core:ListedExchangeTraded2023-03-1314728386core:UnlistedNon-exchangeTraded2023-03-1314728386core:ShareCapital2023-03-1314728386core:SharePremium2023-03-1314728386core:RevaluationReserve2023-03-1314728386core:OtherReservesSubtotal2023-03-1314728386core:RetainedEarningsAccumulatedLosses2023-03-1314728386core:AfterOneYear2023-03-142024-08-3114728386core:WithinOneYear2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:CostValuation2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-142024-08-3114728386core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3114728386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3114728386core:Non-currentFinancialInstrumentscore:CostValuation2023-03-1314728386core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-1314728386core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-1314728386bus:Director12023-03-142024-08-3114728386bus:Director22023-03-142024-08-3114728386bus:Director32023-03-142024-08-3114728386bus:Director42023-03-142024-08-31

BRIDGEOUT HEALTHCARE SERVICES LTD

Registered Number
14728386
(England and Wales)

Unaudited Financial Statements for the Period ended
31 August 2024

BRIDGEOUT HEALTHCARE SERVICES LTD
Company Information
for the period from 14 March 2023 to 31 August 2024

Directors

ATANGA, John Nche, Dr.
ATANGA, Pamela Nyingcho
FINN, Eveline Angwe
FINN, Warren James

Registered Address

Office 6, Paris Council Offices, Community Centre Court Road
Brockworth
Gloucester
GL3 4ET

Registered Number

14728386 (England and Wales)
BRIDGEOUT HEALTHCARE SERVICES LTD
Balance Sheet as at
31 August 2024

Notes

2024

£

£

Current assets
Cash at bank and on hand2,742
2,742
Creditors amounts falling due within one year3(9,343)
Net current assets (liabilities)(6,601)
Total assets less current liabilities(6,601)
Net assets(6,601)
Capital and reserves
Called up share capital100
Profit and loss account(6,701)
Shareholders' funds(6,601)
The financial statements were approved and authorised for issue by the Board of Directors on 30 November 2024, and are signed on its behalf by:
ATANGA, John Nche, Dr.
Director
ATANGA, Pamela Nyingcho
Director
FINN, Warren James
Director

Registered Company No. 14728386
BRIDGEOUT HEALTHCARE SERVICES LTD
Notes to the Financial Statements
for the period ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2024
Average number of employees during the year0
3.Creditors: amounts due within one year

2024

£
Other creditors9,343
Total9,343
4.Directors advances, credits and guarantees
At the balance sheet date, the director's loan account balances are as follows: Warren and Eveline Finn - £3,823 John and Pamela Atanga - £5,520